How to buy Medifast stock | $208.73

Medifast Inc is a personal services business based in the US. Medifast shares (MED) are listed on the NYSE and all prices are listed in US Dollars. Medifast employs 713 staff and has a trailing 12-month revenue of around 0.00.

Medifast stock price (NYSE: MED)

Use our graph to track the performance of MED stocks over time.

Medifast shares at a glance

• Key figures

Information last updated 2021-09-18.

Latest market close	$208.73
52-week range	$137.18 - $335.17
50-day moving average	$237.33
200-day moving average	$258.50
Wall St. target price	$363.33
PE ratio	17.3215
Dividend yield	$5.1 (2.37%)
Earnings per share (TTM)	$12.68

Buy Medifast shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Medifast stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Medifast price performance over time

Historical closes compared with the close of $208.73 from 2021-09-23

1 week (2021-09-17)	-4.93%
1 month (2021-08-24)	-6.62%
3 months (2021-06-24)	-25.03%
6 months (2021-03-24)	-5.57%

1 year (2020-09-24)	26.96%
2 years (2019-09-24)	98.00%
3 years (2018-09-24)	211.49
5 years (2016-09-23)	446.41%

Is Medifast under- or over-valued?

Valuing Medifast stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medifast's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medifast's P/E ratio

Medifast's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Medifast shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Medifast's PEG ratio

Medifast's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medifast's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Medifast's EBITDA

Medifast's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $206.2 million.

The EBITDA is a measure of a Medifast's overall financial performance and is widely used to measure a its profitability.

Medifast financials

Revenue TTM	$1.3 billion
Operating margin TTM	15.57%
Gross profit TTM	$697.8 million
Return on assets TTM	41.5%
Return on equity TTM	96.64%
Profit margin	11.84%
Book value	$16.66
Market capitalisation	$2.6 billion

TTM: trailing 12 months

Shorting Medifast shares

There are currently 341,004 Medifast shares held short by investors – that's known as Medifast's "short interest". This figure is 17% down from 410,954 last month.

There are a few different ways that this level of interest in shorting Medifast shares can be evaluated.

Medifast's "short interest ratio" (SIR)

Medifast's "short interest ratio" (SIR) is the quantity of Medifast shares currently shorted divided by the average quantity of Medifast shares traded daily (recently around 120496.1130742). Medifast's SIR currently stands at 2.83. In other words for every 100,000 Medifast shares traded daily on the market, roughly 2830 shares are currently held short.

However Medifast's short interest can also be evaluated against the total number of Medifast shares, or, against the total number of tradable Medifast shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medifast's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Medifast shares in existence, roughly 30 shares are currently held short) or 0.033% of the tradable shares (for every 100,000 tradable Medifast shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medifast.

Find out more about how you can short Medifast stock.

Medifast share dividends

Dividend payout ratio: 42.51% of net profits

Recently Medifast has paid out, on average, around 42.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medifast shareholders could enjoy a 2.59% return on their shares, in the form of dividend payments. In Medifast's case, that would currently equate to about $5.1 per share.

While Medifast's payout ratio might seem fairly standard, it's worth remembering that Medifast may be investing much of the rest of its net profits in future growth.

Medifast's most recent dividend payout was on 7 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 19 September 2021 (the "ex-dividend date").

Medifast share price volatility

Over the last 12 months, Medifast's shares have ranged in value from as little as $137.181 up to $335.1738. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medifast's is 1.4061. This would suggest that Medifast's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Medifast overview

Medifast, Inc. , through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and its franchisee system. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. .

Frequently asked questions

What percentage of Medifast is owned by insiders or institutions?
Currently 4.426% of Medifast shares are held by insiders and 87.503% by institutions. How many people work for Medifast?
Latest data suggests 713 work at Medifast. When does the fiscal year end for Medifast?
Medifast's fiscal year ends in December. Where is Medifast based?
Medifast's address is: 100 International Drive, Baltimore, MD, United States, 21202 What is Medifast's ISIN number?
Medifast's international securities identification number is: US58470H1014 What is Medifast's CUSIP number?
Medifast's Committee on Uniform Securities Identification Procedures number is: 42221F101